Comparison of Bivalent and Monovalent mRNA Vaccine Boosters.

Carlos K H Wong,Kristy T K Lau,Ivan C H Au,Eric H Y Lau,Benjamin J Cowling

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America（2024）

引用 0|浏览14

暂无评分

摘要

In this cohort study conducted in Hong Kong where both bivalent and monovalent formulations of BNT162b2 were available, there were no significant differences in the mortality or hospitalization between those who received bivalent and monovalent mRNA as second boosters. Bivalent and monovalent mRNA boosters appear equally protective against clinical outcomes.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要